Ex Parte GOEDE et al - Page 2




          Appeal 1997-3391                                                            
          Application 08/212,578                                                      

                                     The claims                                       
                    1.   The claims on appeal are claims 1-7.                         
                    2.   According to applicants' reply brief, the claims             
          stand or fall together (page 1).                                            
                    3.   Claim 1 reads as following (indentation and                  
          paragraph numbering added):                                                 

               A pharmaceutical dosage unit comprising:                               
                    [1] flupirtine, its pharmaceutically acceptable salts             
                         or mixtures thereof and                                      
                    [2] a controlled-release component,                               
                    wherein 0.001 to 20 parts controlled release component            
               are present for each part by weight flupirtine (calculated             
               as flupirtine base)                                                    
                    which results in a release rate of flupirtine between 5           
               and 300 mg per hour, determined in accordance with the                 
               method of USP XXII with apparatus 2 in an aqueous test                 
               solution of pH 1.0 and/or pH 6.8.                                      

                                    The invention                                     
                    4.   Flupirtine is a known pharmaceutical useful as an            
          analgesic (specification, page 1, line 12).                                 
                    5.   According to applicants, its use "sometimes causes           
          a sedative side-effect" (specification, page 1, lines 12-13).               
                    6.   An object of applicants' invention is to provide a           
          solid dosage form of flupirtine in which the sedative side                  



                                        - 2 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007